Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vaccine Injury Look-Back May Overburden Compensation Fund – AAP’s Noyes

Executive Summary

A retroactive extension of the statute of limitations for filing vaccine injury claims could overburden the compensation program, Advisory Commission on Childhood Vaccines Chair Jackie Noyes, American Academy of Pediatrics, said March 7

You may also be interested in...



VICP Compensation Increase For Death Could Overwhelm Budget, HHS Says

HHS is concerned that a House proposal to raise the cash compensation for vaccine-related deaths would overburden the vaccine budget

VICP Compensation Increase For Death Could Overwhelm Budget, HHS Says

HHS is concerned that a House proposal to raise the cash compensation for vaccine-related deaths would overburden the vaccine budget

Vaccine Injury Program Would Award Interim Payments Under Draft Bill

The Vaccine Injury Compensation Program would award interim payment of unreimbursed medical expenses once compensation entitlement is determined, a draft bill by Reps. Dan Burton (R-Ind.) and Henry Waxman (D-Calif.) says

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039460

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel